1. Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?. (18th October 2016) Authors: Bonenfant, J.; Bajeux, E.; Deburghgraeve, V.; Le Page, E.; Edan, G.; Kerbrat, A. Journal: European journal of neurology Issue: Volume 24:Number 2(2017:Feb.) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis. (13th August 2019) Authors: Laplaud, David-Axel; Casey, Romain; Barbin, Laetitia; Debouverie, Marc; De Sèze, Jérôme; Brassat, David; Wiertlewski, Sandrine; Brochet, Bruno; Pelletier, Jean; Vermersch, Patrick; Edan, Gilles; Lebrun-Frenay, Christine; Clavelou, Pierre; Thouvenot, Eric; Camdessanché, Jean-Philippe; Tourbah, Aym... Journal: Neurology Issue: Volume 93:Number 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗